193 related articles for article (PubMed ID: 16197398)
21. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
Peyrin-Biroulet L; Bressenot A; Chone L; Denjean P; Boissel P; Bigard MA; Bronowicki JP
Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
[No Abstract] [Full Text] [Related]
22. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
[TBL] [Abstract][Full Text] [Related]
23. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
Loftus EV
Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
[No Abstract] [Full Text] [Related]
24. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
Lichtenstein GR
Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
[No Abstract] [Full Text] [Related]
25. Guidelines for treatment with infliximab for Crohn's disease.
Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
[TBL] [Abstract][Full Text] [Related]
26. Psoriasis induced by infliximab in a patient suffering from Crohn's disease.
Manni E; Barachini P
Int J Immunopathol Pharmacol; 2009; 22(3):841-4. PubMed ID: 19822070
[TBL] [Abstract][Full Text] [Related]
27. Pustular psoriasis induced by infliximab.
Thurber M; Feasel A; Stroehlein J; Hymes SR
J Drugs Dermatol; 2004; 3(4):439-40. PubMed ID: 15303790
[TBL] [Abstract][Full Text] [Related]
28. Timing infliximab therapy in pediatric Crohn's disease.
Kirschner BS; Huo D
Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
[No Abstract] [Full Text] [Related]
29. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
[TBL] [Abstract][Full Text] [Related]
30. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.
Sands BE; Blank MA; Diamond RH; Barrett JP; Van Deventer SJ
Aliment Pharmacol Ther; 2006 Apr; 23(8):1127-36. PubMed ID: 16611273
[TBL] [Abstract][Full Text] [Related]
31. Re: Fefferman et al.--"Recurrence" of chronic pancreatitis appearing on a patient with underlying Crohn's disease.
Triantafillidis JK; Cheracakis P
Am J Gastroenterol; 2002 Mar; 97(3):761-2. PubMed ID: 11922579
[No Abstract] [Full Text] [Related]
32. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
Lichtenstein GR; Olson A; Travers S; Diamond RH; Chen DM; Pritchard ML; Feagan BG; Cohen RD; Salzberg BA; Hanauer SB; Sandborn WJ
Am J Gastroenterol; 2006 May; 101(5):1030-8. PubMed ID: 16606351
[TBL] [Abstract][Full Text] [Related]
33. Tuberculosis and treatment with infliximab.
Zhang Z; Correa H; Bégué RE
N Engl J Med; 2002 Feb; 346(8):623-6. PubMed ID: 11859880
[No Abstract] [Full Text] [Related]
34. Infliximab-induced psoriasis during therapy for Crohn's disease.
Steinwurz F; Denadai R; Saad-Hossne R; Queiroz ML; Teixeira FV; Romiti R
J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
[TBL] [Abstract][Full Text] [Related]
35. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
[TBL] [Abstract][Full Text] [Related]
36. Remicade approved for children with Crohn's disease.
FDA Consum; 2006; 40(4):6. PubMed ID: 17245830
[No Abstract] [Full Text] [Related]
37. Infliximab-induced psoriasis in children with inflammatory bowel disease.
Hiremath G; Duffy L; Leibowitz I
J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):230-2. PubMed ID: 21240020
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous adverse reaction to infliximab: report of psoriasis developing in 3 patients.
Severs GA; Lawlor TH; Purcell SM; Adler DJ; Thompson R
Cutis; 2007 Sep; 80(3):231-7. PubMed ID: 17956013
[TBL] [Abstract][Full Text] [Related]
39. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
Puli SR; Benage DD
Am J Gastroenterol; 2003 Apr; 98(4):939-40. PubMed ID: 12738486
[No Abstract] [Full Text] [Related]
40. Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab.
Pourciau C; Shwayder T
Pediatr Dermatol; 2010; 27(5):539-40. PubMed ID: 20796241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
